DADUN
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array
Review: mitochondrial defects in breast cancer